METFORMIN SR 500, 750, 1000 MG TABLETS

Product description

Approved country
500 mg : UK, Czech, Latvia, Hungary, The Netherlands, Poland
750mg : UK, Ireland, The Netherlands, Poland
1000mg : UK, The Netherlands, Poland

Composition 500 mg: One prolonged release tablet contains 500 mg metformin hydrochloride equivalent to 390 mg metformin.
750 mg: One prolonged release tablet contains 750 mg metformin hydrochloride equivalent to 585 mg metformin .
1000 mg: One prolonged release tablet contains 1000 mg metformin hydrochloride equivalent to 780 mg metformin .

Pharmaceutical Form Prolonged-release tablet
500 mg: White, shallow convex, capsule-shaped tablet marked “XR” on one side , and blank on the other side, dimension : 20x9mm.
750 mg: White, shallow convex, capsule-shaped tablet marked “SR 1” on one side, and blank on the other side, dimension : 20x9mm.
1000 mg: White, shallow convex, capsule-shaped tablet marked “SR 2” on one side, and blank on the other side, dimension : 22.25x9mm.

Therapeutic indications Treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control.
METFORMIN SR may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin

Type of container
500mg: PVC/PVDC aluminium blisters.
Blister packs of 28, 30, 56, 60 & 120 prolonged-release tablets.

750mg: PVC/PVDC aluminium blisters.
Blister packs of 28, 30, 56, 60 & 120 prolonged-release tablets.

1000mg: PVC/PVDC aluminium blisters.
Blister packs of 28, 30, 56, 60 & 120 prolonged-release tablets.

Shelf life
Shelf life as packaged for sale: 36 months

Read more

Specifications

Categories Finished Dosage Forms
Sales markets Western Europe
Supplied from Indonesia
Show more specifications

Products from other suppliers

METFORMIN SR 500, 750, 1000 MG TABLETS

Contact information

Address

Telephone

Website

View all contact information